InMed Pharmaceuticals Inc (INM) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $1.38 (-0.72%), Market cap $0.01B, 52-week low–high $0.61 ~ $3.87.
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceuticals and BayMedica Commercial. The InMed Pharmaceuticals segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with unmet medical needs. The company's lead product consists of INM-755, a cannabinol top
Financial statements, price targets, institutional (13F) holdings and related news for InMed Pharmaceuticals Inc are updated in real time on BlackAll Trade.
InMed Pharmaceuticals Inc trades at $1.38 (-0.72%). Real-time quotes and charts are available on BlackAll Trade.
InMed Pharmaceuticals Inc has a market cap of about $0.01B.
InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. The company operates through two segments, InMed Pharmaceu